Literature DB >> 26069004

Assessment of Motor Coordination and Balance in Mice Using the Rotarod, Elevated Bridge, and Footprint Tests.

Simon P Brooks1, Rebecca C Trueman1, Stephen B Dunnett1.   

Abstract

In order fully to utilize animal models of disease states, to test experimental therapeutics, and to understand the underlying pathophysiology of neurodegenerative disease, behavioral characterization of the model is essential. Deterioration of normal motor function within a disease state signals the progression of an underlying pathological process, and identifies disease-sensitive time points according to which the onset of therapeutic trials may be scheduled. Deterioration in the performance of motor tasks may also indicate the point when motor deficits begin to compromise our ability to measure other deficits within cognitive and behavioral domains. In acute therapeutic trials, the separation of motor from cognitive or behavioral function may be crucial in determining the functional specificity of the drug effect. If we are to accurately measure motor performance in disease progression or during drug trials, tests of motor function that have been highly optimized with respect to sensitivity must be applied. Since motor coordination and balance are essential to normal motor function, tests that probe these facets are ideal for the purpose. In this chapter, we describe in detail three test protocols that principally measure motor coordination (the rotarod and footprint tests) and balance (the elevated bridge test) in mice. Curr. Protoc. Mouse Biol. 2:37-53 © 2012 by John Wiley & Sons, Inc.
Copyright © 2012 John Wiley & Sons, Inc.

Entities:  

Keywords:  balance; coordination; elevated bridge; footprint; gait; mice; motor tests; rotarod

Year:  2012        PMID: 26069004     DOI: 10.1002/9780470942390.mo110165

Source DB:  PubMed          Journal:  Curr Protoc Mouse Biol        ISSN: 2161-2617


  17 in total

Review 1.  Peripheral Neuropathy in Mouse Models of Diabetes.

Authors:  Corinne G Jolivalt; Katie E Frizzi; Lucie Guernsey; Alex Marquez; Joseline Ochoa; Maria Rodriguez; Nigel A Calcutt
Journal:  Curr Protoc Mouse Biol       Date:  2016-09-01

2.  In vivo compression and imaging in mouse brain to measure the effects of solid stress.

Authors:  Hadi T Nia; Meenal Datta; Giorgio Seano; Sue Zhang; William W Ho; Sylvie Roberge; Peigen Huang; Lance L Munn; Rakesh K Jain
Journal:  Nat Protoc       Date:  2020-07-17       Impact factor: 13.491

3.  A protocol for evaluation of Rett Syndrome symptom improvement by metabolic modulators in Mecp2-mutant mice.

Authors:  Christie M Buchovecky; Misty G Hill; Jennifer M Borkey; Stephanie M Kyle; Monica J Justice
Journal:  Curr Protoc Mouse Biol       Date:  2013

4.  Mitochondrial FAD shortage in SLC25A32 deficiency affects folate-mediated one-carbon metabolism.

Authors:  Min-Zhi Peng; Yong-Xian Shao; Xiu-Zhen Li; Kang-Di Zhang; Yan-Na Cai; Yun-Ting Lin; Min-Yan Jiang; Zong-Cai Liu; Xue-Ying Su; Wen Zhang; Xiao-Ling Jiang; Li Liu
Journal:  Cell Mol Life Sci       Date:  2022-06-21       Impact factor: 9.261

5.  Induction of broadly reactive influenza antibodies increases susceptibility to autoimmunity.

Authors:  Jocelyn G Labombarde; Meenu R Pillai; Marie Wehenkel; Chun-Yang Lin; Rachael Keating; Scott A Brown; Jeremy Chase Crawford; David C Brice; Ashley H Castellaw; Alexandra H Mandarano; Clifford S Guy; Juan R Mejia; Carlessia D Lewis; Ti-Cheng Chang; Christine M Oshansky; Sook-San Wong; Richard J Webby; Mei Yan; Quan-Zhen Li; Tony N Marion; Paul G Thomas; Maureen A McGargill
Journal:  Cell Rep       Date:  2022-03-08       Impact factor: 9.995

6.  Effects of long-term infliximab and tocilizumab treatment on anxiety-like behavior and cognitive function in naive rats.

Authors:  Frideriki Poutoglidou; Chryssa Pourzitaki; Maria Eleni Manthou; Foteini Malliou; Athanasios Saitis; Ioannis Tsimoulas; Spyridon Panagiotopoulos; Dimitrios Kouvelas
Journal:  Pharmacol Rep       Date:  2021-09-27       Impact factor: 3.024

7.  Implantation of undifferentiated and pre-differentiated human neural stem cells in the R6/2 transgenic mouse model of Huntington's disease.

Authors:  Gehan El-Akabawy; Ivan Rattray; Saga M Johansson; Richard Gale; Gillian Bates; Michel Modo
Journal:  BMC Neurosci       Date:  2012-08-09       Impact factor: 3.288

8.  Phosphorylation of Parkin at serine 65 is essential for its activation in vivo.

Authors:  Thomas G McWilliams; Erica Barini; Risto Pohjolan-Pirhonen; Simon P Brooks; François Singh; Sophie Burel; Kristin Balk; Atul Kumar; Lambert Montava-Garriga; Alan R Prescott; Sidi Mohamed Hassoun; François Mouton-Liger; Graeme Ball; Rachel Hills; Axel Knebel; Ayse Ulusoy; Donato A Di Monte; Jevgenia Tamjar; Odetta Antico; Kyle Fears; Laura Smith; Riccardo Brambilla; Eino Palin; Miko Valori; Johanna Eerola-Rautio; Pentti Tienari; Olga Corti; Stephen B Dunnett; Ian G Ganley; Anu Suomalainen; Miratul M K Muqit
Journal:  Open Biol       Date:  2018-11-07       Impact factor: 6.411

9.  Telomerase gene therapy ameliorates the effects of neurodegeneration associated to short telomeres in mice.

Authors:  Kurt Whittemore; Aksinya Derevyanko; Paula Martinez; Rosa Serrano; Martí Pumarola; Fàtima Bosch; Maria A Blasco
Journal:  Aging (Albany NY)       Date:  2019-05-28       Impact factor: 5.682

10.  Insights from zebrafish and mouse models on the activity and safety of ar-turmerone as a potential drug candidate for the treatment of epilepsy.

Authors:  Adriana Monserrath Orellana-Paucar; Tatiana Afrikanova; Joice Thomas; Yelaman K Aibuldinov; Wim Dehaen; Peter A M de Witte; Camila V Esguerra
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.